JDRF in Partnership with Animas

JDRF in Groundbreaking Partnership with Animas to Develop First-Generation Artificial Pancreas System

The development of an artificial pancreas—a fully automated system to dispense insulin to people with diabetes based on real-time changes in blood sugar levels—
would be among the most revolutionary advancements in treating type 1 diabetes. Today, JDRF took the first steps on that path, with the groundbreaking announcement
of an innovative partnership with Animas Corporation, a Johnson & Johnson company that is a leading pump manufacturer, to develop a first-generation artificial pancreas: an automated system to help people with type 1 diabetes better control their disease.

Read more…